Kaplan-Meier analysis revealed that higher NCAPD3 expression in lung cancer patients was associated with a worse clinical outcome compared to low expression (log-rank p = 0.0015) (Fig. 1g). This evidence concerns the gene NCAPD3 and lung cancer.